NCT01296932
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01296932
Title BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA | DEU | BEL

Facility Status City State Zip Country Details
Brussels - UNIV Saint-Luc Brussels 1200 Belgium Details
Edegem - UNIV UZ Antwerpen Edegem 2650 Belgium Details
UNIV UZ Gent Ghent 9000 Belgium Details
INS Paoli-Calmettes Marseille 13273 France Details
CTR Investigation Clinique, onco, Montpellier Montpellier 34295 France Details
INS Universitaire du Cancer Toulouse 31059 France Details
Universitätsklinikum Köln (AöR) Cologne 50937 Germany Details
Universitätsklinikum Frankfurt Frankfurt am Main 60590 Germany Details
Universitätsklinikum Heidelberg Heidelberg 69120 Germany Details
Universitätsklinikum Ulm Ulm 89081 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field